Abstract
Introduction
Coronary heart disease (CHD) remains one of the leading causes of death in both genders in developed countries. 1 The incidence of mortality due to cardiovascular disease has been diminishing over the previous 3 decades in many developed countries. 2 Reduced incidences, promotion of secondary prevention measures, use of new treatments during
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Trends of case fatality rate 234 ARYA Atheroscler 2015; Volume 11, Issue 4 the acute phase, and improved survival after myocardial infarction (MI) have contributed to the declining mortality rates. [3] [4] [5] However, MI is a primary cause of mortality and disability in the Iranian population. 6 Age, sex, cardiovascular risk factors, coronary history, acute MI (AMI) location, complications, treatments received during hospitalization and after hospital discharge, and the type of hospital are among the variables that may influence early or late mortality following an AMI. [7] [8] [9] [10] Most of the centers showed a decline in short-term case fatality rate, but the Isfahan center, Iran, did not. 5 The purpose of the present study was the analysis of the trends of case fatality rate of AMI in Isfahan and Najafabad based on gender, age groups, and type of AMI in patients treated during [2000] [2001] [2002] [2003] [2004] [2005] [2006] [2007] [2008] [2009] . Type of AMI was determined according to the International Classification of Disease, version 10 (ICD10) and using streptokinase.
Materials and Methods
Isfahan is a city in the center of Iran, an Eastern Mediterranean country, and is the second largest city of Iran. Previous studies have shown a relatively high rate of cardiovascular risk factors in this industrial city. [11] [12] [13] [14] [15] During the study period, about 13 hospitals were admitting and managing patients with CHD in Isfahan. More than 75% of patients who had experienced MI were managed in 4 public hospitals and the rest in the remaining 9 private hospitals. Except for military hospitals, which did not allow access to their patients' records, other hospital records were evaluated. Among these hospitals, 4 were private and 9 public or university hospitals. 16 In this registry, all possible CHD events were registered disregarding the Multinational Monitoring of Trends and Determinants in Cardiovascular Disease (MONICA) age limitation. In this study, the MONICA definition (non-fatal definite events and fatal definite or possible events) is used for MI events. Moreover, only first events and patients classified as one group according ICD10 are included.
The research team involved in the program consisted of cardiologists and general practitioners, a number of nurses trained in receiving and recording patients' information, and professional biostatistician and epidemiologist. Identification and separation of patients with AMI based on ICD10 was performed by a cardiologist. Hospital discharge lists were used for case finding. Records of patients hospitalized in cardiology wards, coronary care units, or other wards but under the complete or partial supervision of cardiologists, were evaluated for possible signs and symptoms of CHD events. Basic information related to patients were collected by trained nurses, who used special forms to interview patients or obtained information from their hospital records. Symptoms and cardiac enzymes codes were classified in a manner similar to the MONICA project. 17 They summarized accurate records in special checklists containing information on age, sex, event and hospitalization dates, symptoms, history of previous MI, enzymes, admission electrocardiogram, whether the event was iatrogenic, survival status at discharge and after 28 days follow-up, and whether thrombolytic therapy was used during hospitalization. An expert nurse with special training in the MONICA registration system checked the filled records. Moreover, 10% of the checklists were randomly chosen and refilled by the expert nurse using the original hospital records and compared with those completed by registered nurses to see if any mistakes occurred. Then, data was collected from the Isfahan Cardiovascular Research Center (ICRC). As the center of Isfahan Province, MI patients who live in other cities of the province are also admitted to these hospitals. In order to calculate MI survival rate in Isfahan, only records from Isfahan and Najafabad city inhabitants were included in the study. 16 A period of 28 days was used to define the casefatality rate and to distinguish between events. 18 All discharged MI patients were followed using telephone calls, and if not available, reached through their address. The patients or close family members were asked about patients' health status. If a patient had died during the first 28 days after the event, death scenario was asked. 16 Detailed descriptions of the methods used in this project have been provided in previous reports. 16, [19] [20] [21] [22] [23] [24] Overall, 14,450 patients (10,334 men and 4116 women) with first AMI, who were inhabitants of Isfahan and Najafabad were entered into the study. Subsequently, 886 patients (564 men and 322 women) were excluded because their AMI type was not determined according to the ICD10. Furthermore, 118 patients (82 men and 36 women) were exclude from the study, because they died during the 28 days after the first attack without any sign of cardiovascular disease and due to accident, suicide, homicide, chronic obstructive pulmonary disease, cancer, liver cirrhosis, rheumatic heart disease, vascular disease, or atherosclerosis. In addition, 418 patients (292 men and 126 women) were excluded because outcome was unknown. Moreover, 128 patients (89 men and 39 women) were excluded from the study, because the exact date of occurrence or death from the disease was not specified and the 28 days duration after the attack could not be calculated in these cases. 17 Therefore, 12,900 patients, 9307 (72.15%) men and 3593 (27.85%) women, remained in the study.
The study period, from 2000 to 2009, was divided into 5 2-year periods (2000-2001, 2002-2003, 2004-2005, 2006-2007, and 2008-2009 ). Case fatality rates were adjusted for age through direct standardization. Standardization was based on 4 age groups; ≤ 40, 41-60, 61-80, and ≥ 81 years. In order to compare age average in the study, t-test and analysis of variance (ANOVA) were used. To assess the case fatality rate according to each period, Kaplan-Meier analysis, and to compare case fatality rate, log-rank test were used. Short-term (28 days) case fatality hazard ratio (HR) was calculated using the Cox regression model for every 2-year period. The first period (2000-2001) was considered as reference, and other periods were compared with this group and 95% confidence interval (CI) was calculated. The trend of streptokinase use in the treatment of AMI in hospitals was evaluated in every 2-year period. SPSS software (version 15, SPSS Inc., Chicago, IL, USA) was used for data analysis. The significance value was set to P < 0.050.
Results
In total, this study included 12,900 fatal and nonfatal first AMI events, of which 9307 (72.15%) were men and 3593 (27.85%) women. Sex ratio (male/female) was 2.59. Patient's demographic and clinical data is presented in table 1. The distribution of first AMI and 28 days case fatality rate in 10 years (for every 2 years separately) of the study periods is shown in table 2. Of the 12,900 patients with AMI entered into the study, 1198 died during the 28 days after their MI event (overall case fatality rate = 09.30% and survival rate = 90.70%). Of the 9307 men, 697 died (case fatality rate = 07.50% and survival rate = 92.50%) and of the 3593 women, 501 died (case fatality rate = 13.90% and survival rate = 86.10%) (P < 0.001).
A steady descending trend was observed in the 28 days case fatality rate during the study period Table 2) .
Mean age of all patients was 61.80 ± 12.60; in men it was 60.00 ± 12.50 and in women 66.72 ± 11.34. This difference was statically significant (P ≤ 0.0010). To examine changes in age of disease occurrence over time, the study period was divided into 5 2-year periods. Mean age of all patients increased from 61.36 ± 12.19 in the primary period (2000-2001) to 62.61 ± 12.81 in the final period (2008) (2009) ). This difference was statically significant (P = 0.0070). There was a raising trend in mean age in men and women in the study period. For women, in the primary period, it was 65.38 ± 10.95 and in the final period was 67.15 ± 11.72 (P = 0.0200). For men, in the primary period, it was 59.75 ± 12.29 and in the final period 59.84 ± 12.54 (P = 0.0170) ( Table 3 ). In addition, this trend was observed in mean age at time of death. Thus, in the primary period, it was 68.00 ± 10.60 and in the final period, 71.40 ± 9.53 (P = 0.0200). This trend was observed in men and women, but it was only significant in women. For women, in the primary period, it was 68.86 ± 10.41 and in the final period, 73.11 ± 08.94 (P = 0.0440). For men, in the primary period, it was 67.40 ± 10.73, and in the final period, 70.31 ± 08.70 (P = 0.1640) ( Table 3) . Table 4 shows the trends of case fatality rate for each age group. Case fatality rate decreased in a steady pattern in all age groups with the increase in age. Consequently, there was a 60, 60, 19. (Table 4) .
In this study, based on ICD10, AMI was classified into 6 groups; acute transmural MI of anterior wall, acute transmural MI of inferior wall, acute transmural MI of other site, acute transmural MI of unspecified site, acute sub endocardial MI and AMI, and unspecified. Because the number of patients in acute transmural MI of other sites and acute transmural MI of unspecified site was small and very unstable, we considered these two groups as one group. In Isfahan and Najafabad, based ICD10, from 2000 to 2009 no evident trend was observed in 10 years case fatality rate. However, difference in average case fatality rate between types of AMI, according to ICD10, was statistically significant (P < 0.0001) ( Table 5 ).
In addition, use of streptokinase in the treatment service during the study period had no clear trend. In this study, the majority of patients were men (72.10% men and 27.90% women) and women were older (66.77 ± 11.37 vs. 60.00 ± 12.54 years; P < 0.0010). The 28 days case fatality rate was higher in women than men (13.90 vs. 07.50%; < 0.0001). In a study conducted by Carine Milcent et al. in the French Hospitals Database, most patients were men (70% men and 30% women) and women were older (75 vs. 63 years of age; P < 0.0010) and had a higher rate of hospital mortality (14.80 vs. 06.10%; P < 0.0001) than men. 25 This was in agreement with the findings of the current study. However, the present analysis confirms the higher 28 days case fatality rate from AMI in women; the so-called "gender gap" reported in other studies. [26] [27] [28] [29] In previous studies, we observed that crude hospital mortality rates for AMI in women was higher than men. This difference may be partly due to the higher average age of women at the time of disease occurrence and higher prevalence of comorbidities in women compared with men. 26 More frequent use of revascularization procedures in men may also account for the fewer deaths. Indeed, men with AMI tend to undergo more aggressive hospital treatments than women. 30, 31 We observed a similar result in the Iranian treatment system; during the study, an average higher proportion of men received streptokinase than women (55.70% men and 41.70% women). However, the impact of lower rates of revascularization is controversial. In some studies, older age and higher baseline risk are presented as the causes of higher rates of mortality in women. 32, 33 In addition, some studies inferred that treatment in women had no effect on shortterm survival from AMI. 27 38 In the study by MacIntyre et al., 28 days case fatality rate increased with increasing of age. 39 However, in this study, with the rising trend in mean age in the disease occurrence a steady decline was observed in case fatality rate. It is evident that the severity of infarctions decreased over time. A hypothesis is that the increasing use of medications such as aspirin and β-blockers before admission may reduce the size and severity of infarctions. 40 Therefore, over time this could be effective in reducing the AMI case fatality rate.
Population-based studies all documented a favorable decline in early mortality among younger individuals contrasting with a persistently high fatality rate among the elderly over a period of time ranging from 1975 to 1995. 2, [41] [42] [43] [44] More importantly, the mortality rate of infarction in the community remained high and was consistently higher than that reported in clinical trials, reflecting their inherent selection processes. 45 Although only clinical trials can test the efficacy of a new treatment, reports from community surveillance present important complementary insights into the effectiveness of care and treatments once implement. The current study demonstrates that the marked improvement in early fatalities after MI persisted over time and that notable survival gains were realized among the women and elderly, in whom discrepancy had been detected previously. 43 This article was conducted based on the MONICA project in Isfahan with the support and ethical approval of ICRC with the code 84130, in year 2012.
Limitations
A difficulty of this study is a lack of complete, community-based case ascertainment, which includes protocols for finding community fatal and non-fatal MI cases who are not admitted to hospitals. Most important limitation of the study is the lack of data about out-of-hospital fatal cases, such as MI cases managed at home or in health centers. This figure might be unimportant since MI event is considered an emergency in the Iranian health care system, and all hospitals should admit such patients regardless of their insurance status. In the Danish MONICA population, this figure was measured to be > 01% of total MI cases in a year. 46 Therefore, omitting these patients will not lead to a sham decline in MI case fatality rates.
Conclusion
We have demonstrated a consistent decrease in case fatality rate following a first MI in Isfahan, during a 10-year period from 2000 to 2009. The decrease in the trend of case fatality rate in both genders and all age groups was observable. There was 29.46% reduction in case fatality rate in the final period 
